High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$40.0M
$39,999,780
Total Sells (Filtered)
$1.8M
$1,846,957
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-09 | $139,336 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-09 | $704,657 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-06 | $14,466 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-06 | $71,572 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-05 | $6,769 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-05 | $33,464 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2026-03-04 | $11,229 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-04 | $54,062 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
Other
|
2026-03-04 | $9,971 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $49,289 | S | Form 4 |
|
BCAX
M
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
Other
2026-03-04
$61,774
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-04 | $61,774 | M | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
2026-03-04
$301,920
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
|
2026-03-04 | $301,920 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2026-03-03 | $48,858 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-03-03 | $315,893x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
Other
|
2026-03-03 | $51,371x2 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-03 | $246,910 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-03 | $758 | M | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-03
$3,690
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-03 | $3,690 | S | Form 4 |
|
BCAX
P
Bicara Therapeutics Inc.
RA CAPITAL MANAGEMENT, L.P.
• Director
Discretionary Buy
2026-02-26
$39,999,780MEGAx2
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Director
Discretionary Buy
|
2026-02-26 | $39,999,780MEGAx2 | P | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2026-02-25 | $11,779 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-02-25 | $65,501x2 | S | Form 4 |